Skip to main content

Table 1 Characteristics of Patients and Expanded NK Cells for Clinical Trial

From: Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial

Patient Breed Age Sex Weight (kg) Injection #1a
(× 106)
Viability (%) Injection #2a
(× 106)
Viability (%)
1 Black Lab 14.8 M 29.6 30 79.3 0.3 1.0
2 St. Bernard 9.1 M 59 14.3 80.2 11.04 96.0
3 Shepherd Mix 9.1 M 23.8 392 98.9 155 100.0
4 Shepherd Mix 5.8 M 46 114.63 94.8 139.7 99.0
5 St. Bernard 1.2 F 57.6 75.93 98.6 26.7 97.2
6 St. Bernard 6.3 M 94 129.5 99.2 86.9 99.2
7 Pyrenees 7.5 F 57.1 139.5 95.0 94.5 96.0
8 Doberman 5.0 M 66 25 70.0 280 76.0
9 Retriever Mix 8.9 F 32 180 95.0 175 94.0
10 Rhodesian Ridgeback 10.2 F 35.1 115 95.0 17 95.0
  1. aExpanded NK cells were documented to be LPS and Mycoplasma negative prior to adoptive transfer